Brexit – deal or no deal for labelling?

The time for the UK to leave the EU is fast approaching. With March 29th 2019 the official date. The post-Brexit transition period is in fact set to run until December 31st 2020, meaning the chances are very high that the UK-EU relationship will be staying the same until then, but two years in the…


Playing by the rules: avoiding process roadblocks with business rules

Keeping up with changing regulations Notwithstanding the upcoming implementation of the new EU MDR in May 2020, many organisations in the medical devices, pharmaceutical, chemicals and cosmetics industries are experiencing unprecedented demands from regulatory authorities and consumers alike. Product labelling must be clearer, more informative and published electronically in addition to print. It must also…


5 ways to make your supply chain more efficient

Life Sciences is a heavily regulated industry facing ever-changing regulation and legislation. It is increasingly important therefore, to ensure your organisation puts the necessary processes in place in order to remain compliant when it comes to labelling. Improving the efficiency of labelling and artwork processes across your supply chain is one way to do this….


A strategic, enterprise-wide approach to labelling: how can your medical device organisation benefit?

Global medical device companies are increasingly looking at labelling from a strategic perspective. They have recognised that accurate labelling is critical for maintaining compliance, ensuring brand consistency and improving operational efficiency, with all three helping to support business growth. To work as efficiently as possible, labelling needs to be integrated into an enterprise business process,…


Labelling digitalisation – the importance of consistency

When it comes to the medical devices supply chain, it can often seem to be made up of a series of isolated steps from product development through to the patient or healthcare provider. Labelling digitalisation across the supply chain therefore, can help build a more integrated, fully transparent supply chain for all involved in the…


What’s new on the Kallik website?

Here at Kallik we’ve been working hard to improve our website to make it easier and quicker for you to discover what you need to know If you class your organisation as a heavily regulated industry facing challenges with keeping your labelling compliant or simply being uncertain about current levels of compliance, then you might…



Overcoming cultural challenges in the workplace when adopting new technologies

Processes and routines are two things that could be considered essential within the workplace. They are necessary tools to keep workflow going, businesses progressing, and employees focused on a day-to-day basis. But are they enabling change? As important as it is to have recurring methods in place, the introduction of new systems and procedures can…


Labeling: Unlocking the Locked-In Data

It’s been widely acknowledged and accepted by leading thinkers in the pharma industry that, in comparison to other industries such as automotive and retail, it lacks the vital innovative and modern methods that are being encapsulated by the fourth industrial revolution, Industry 4.0. It is all too common-place in the industry to see high inventories,…


The Effect of New Technologies on Drug Development

The development of new technology is playing a pivotal role in the advancement of both patient autonomy and drug development. It’s a huge challenge for regulators to ensure drugs being manufactured are adhering to uniform standards of quality and safety. Graham Francis, Product Marketing Manager at Kallik, explains how data integrity should be a top…